226 related articles for article (PubMed ID: 12014501)
1. Tumor suppressor PTEN is mutated in canine osteosarcoma cell lines and tumors.
Levine RA; Forest T; Smith C
Vet Pathol; 2002 May; 39(3):372-8. PubMed ID: 12014501
[TBL] [Abstract][Full Text] [Related]
2. Expression and significance of p53, rb, p21/waf-1, p16/ink-4a, and PTEN tumor suppressors in canine melanoma.
Koenig A; Bianco SR; Fosmire S; Wojcieszyn J; Modiano JF
Vet Pathol; 2002 Jul; 39(4):458-72. PubMed ID: 12126149
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of p53 and retinoblastoma family pathways in canine osteosarcoma cell lines.
Levine RA; Fleischli MA
Vet Pathol; 2000 Jan; 37(1):54-61. PubMed ID: 10643981
[TBL] [Abstract][Full Text] [Related]
4. Characterization of canine osteosarcoma by array comparative genomic hybridization and RT-qPCR: signatures of genomic imbalance in canine osteosarcoma parallel the human counterpart.
Angstadt AY; Motsinger-Reif A; Thomas R; Kisseberth WC; Guillermo Couto C; Duval DL; Nielsen DM; Modiano JF; Breen M
Genes Chromosomes Cancer; 2011 Nov; 50(11):859-74. PubMed ID: 21837709
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical detection of p53, PTEN, Rb, and p16 in canine osteosarcoma using tissue microarray.
Russell DS; Jaworski L; Kisseberth WC
J Vet Diagn Invest; 2018 Jul; 30(4):504-509. PubMed ID: 29629647
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of the sis oncogene in a canine osteosarcoma cell line.
Levine RA
Vet Pathol; 2002 May; 39(3):411-2. PubMed ID: 12014510
[TBL] [Abstract][Full Text] [Related]
7. Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma.
Fieten H; Spee B; Ijzer J; Kik MJ; Penning LC; Kirpensteijn J
Vet Pathol; 2009 Sep; 46(5):869-77. PubMed ID: 19429984
[TBL] [Abstract][Full Text] [Related]
8. Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells.
St-Germain ME; Gagnon V; Mathieu I; Parent S; Asselin E
Int J Oncol; 2004 May; 24(5):1311-24. PubMed ID: 15067356
[TBL] [Abstract][Full Text] [Related]
9. Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation.
Soria JC; Lee HY; Lee JI; Wang L; Issa JP; Kemp BL; Liu DD; Kurie JM; Mao L; Khuri FR
Clin Cancer Res; 2002 May; 8(5):1178-84. PubMed ID: 12006535
[TBL] [Abstract][Full Text] [Related]
10. Osteoprotegerin activates osteosarcoma cells that co-express RANK and RANKL.
Marley K; Bracha S; Seguin B
Exp Cell Res; 2015 Oct; 338(1):32-8. PubMed ID: 26254896
[TBL] [Abstract][Full Text] [Related]
11. PTEN expression is reduced in a subset of sporadic thyroid carcinomas: evidence that PTEN-growth suppressing activity in thyroid cancer cells mediated by p27kip1.
Bruni P; Boccia A; Baldassarre G; Trapasso F; Santoro M; Chiappetta G; Fusco A; Viglietto G
Oncogene; 2000 Jun; 19(28):3146-55. PubMed ID: 10918569
[TBL] [Abstract][Full Text] [Related]
12. PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanismsin haematological malignancies.
Dahia PL; Aguiar RC; Alberta J; Kum JB; Caron S; Sill H; Marsh DJ; Ritz J; Freedman A; Stiles C; Eng C
Hum Mol Genet; 1999 Feb; 8(2):185-93. PubMed ID: 9931326
[TBL] [Abstract][Full Text] [Related]
13. [Loss and inactivation of PTEN/MMAC1/TEP1 gene in lung cancer].
Zhang L; Liu T; Liu H; Gao J; Gu C
Zhonghua Bing Li Xue Za Zhi; 2000 Apr; 29(2):85-8. PubMed ID: 11866895
[TBL] [Abstract][Full Text] [Related]
14. The relationship between PTEN expression and anoikis in human lung carcinoma cell lines.
Lei QY; Wang LY; Dai ZY; Zha XL
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Jul; 34(4):463-8. PubMed ID: 12098769
[TBL] [Abstract][Full Text] [Related]
15. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas.
Kurose K; Zhou XP; Araki T; Cannistra SA; Maher ER; Eng C
Am J Pathol; 2001 Jun; 158(6):2097-106. PubMed ID: 11395387
[TBL] [Abstract][Full Text] [Related]
16. [Expression of phosphatase and tensin homology deleted on chromosome ten(PTEN) and p53 protein and their significance in human hepatocellular carcinomas].
Cheng LM; Wang SY; Lin JS
Ai Zheng; 2003 Jan; 22(1):42-5. PubMed ID: 12561434
[TBL] [Abstract][Full Text] [Related]
17. Expression of the tumor suppressor genes NF2, 4.1B, and TSLC1 in canine meningiomas.
Dickinson PJ; Surace EI; Cambell M; Higgins RJ; Leutenegger CM; Bollen AW; LeCouteur RA; Gutmann DH
Vet Pathol; 2009 Sep; 46(5):884-92. PubMed ID: 19429976
[TBL] [Abstract][Full Text] [Related]
18. HES1, a target of Notch signaling, is elevated in canine osteosarcoma, but reduced in the most aggressive tumors.
Dailey DD; Anfinsen KP; Pfaff LE; Ehrhart EJ; Charles JB; Bønsdorff TB; Thamm DH; Powers BE; Jonasdottir TJ; Duval DL
BMC Vet Res; 2013 Jul; 9():130. PubMed ID: 23816051
[TBL] [Abstract][Full Text] [Related]
19. Genetic derangements in the tumor suppressor gene PTEN in endometrial precancers as prognostic markers for cancer development: a population-based study from northern Norway with long-term follow-up.
Orbo A; Kaino T; Arnes M; Kopp M; Eklo K
Gynecol Oncol; 2004 Oct; 95(1):82-8. PubMed ID: 15385114
[TBL] [Abstract][Full Text] [Related]
20. PTEN mutational spectra, expression levels, and subcellular localization in microsatellite stable and unstable colorectal cancers.
Zhou XP; Loukola A; Salovaara R; Nystrom-Lahti M; Peltomäki P; de la Chapelle A; Aaltonen LA; Eng C
Am J Pathol; 2002 Aug; 161(2):439-47. PubMed ID: 12163369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
